Form 4: Xerox Legal Officer's Routine RSU Vesting

Sentiment:

Insider Transaction Report


Xerox Holdings Corp's Chief Legal Officer, Colon Flor, reported the scheduled vesting of Restricted Stock Units and subsequent tax-related share dispositions.

Summary

  • Colon Flor, Chief Legal Officer and Corporate Secretary of Xerox Holdings Corp, reported transactions related to the vesting of Restricted Stock Units (RSUs) on March 11, 2026.
  • A total of 48,374 RSUs from a May 21, 2025 grant (originally 145,138 units) vested, converting into an equal number of common stock shares.
  • Of the common stock acquired from this vesting, 19,223 shares were withheld and disposed of for taxes at a price of $1.75 per share.
  • An additional 9,484 RSUs from a March 11, 2024 grant (originally 28,453 units) also vested, converting into common stock.
  • From this second vesting event, 3,922 common stock shares were withheld and disposed of for taxes, also at a price of $1.75 per share.
  • Following these transactions, Colon Flor beneficially owns 144,187 Restricted Stock Units and 46,384 shares of Common Stock from the first grant, and 134,703 Restricted Stock Units and 51,946 shares of Common Stock from the second grant.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event. It reflects routine executive compensation and retention, which is a normal part of corporate operations, without indicating any new fundamental insights into the company's performance or strategic direction.

Positives

  • The vesting of Restricted Stock Units represents a scheduled compensation event for the Chief Legal Officer, indicating continued executive retention and alignment with shareholder interests.
  • The conversion of RSUs to common stock increases the executive's direct ownership of company shares, albeit partially offset by tax withholdings.

Negatives

  • A portion of the vested common stock (19,223 shares and 3,922 shares) was disposed of to cover tax obligations, resulting in a reduction of the executive's direct shareholdings.

Future Outlook

The remaining portions of the May 21, 2025 RSU grant are scheduled to vest equally over the following eight quarters after March 11, 2026. The remaining portions of the March 11, 2024 RSU grant are scheduled to vest on the second and third anniversaries of the grant date.

Industry Context

StockSavvy.ai notes that this Form 4 filing details a routine insider transaction related to executive compensation. Such filings are common across publicly traded companies as part of their equity incentive plans, reflecting scheduled vesting events rather than discretionary open-market purchases or sales. This type of transaction is standard practice for compensating executives and aligning their interests with long-term company performance.

Stakeholder Impact

  • Shareholders: The vesting and subsequent tax-related disposition of shares by an executive is a routine event and generally has minimal direct impact on the broader shareholder base or stock price.
  • Employees: This filing pertains to executive compensation and does not directly impact the general employee base.
  • Management: The vesting of RSUs represents a component of the Chief Legal Officer's compensation, reinforcing their financial interest in the company's performance.

Next Steps

  • The remaining 100,764 Restricted Stock Units from the May 21, 2025 grant are scheduled to vest equally over the next eight quarters.
  • The remaining 19,000 Restricted Stock Units from the March 11, 2024 grant are scheduled to vest on the second and third anniversaries of the grant date.

Key Dates

DateDescription
03/11/2024Grant date for an award of 28,453 Restricted Stock Units to Colon Flor.
05/21/2025Grant date for an award of 145,138 Restricted Stock Units to Colon Flor.
03/11/2026Vesting date for 33.33% (48,374 units) of the May 21, 2025 RSU grant and the first installment (9,484 units) of the March 11, 2024 RSU grant.
03/13/2026Date the Statement of Changes in Beneficial Ownership (Form 4) was signed.

Recommendation

hold

This Form 4 filing details routine, pre-scheduled executive compensation events (RSU vesting and tax-related share dispositions). It does not provide new material information regarding Xerox Holdings Corp's operational performance, financial health, or strategic outlook. Therefore, a seasoned investor or institution would likely maintain their current position based solely on this filing, awaiting more substantive corporate announcements for any change in investment thesis.

Keywords

Xerox Holdings Corp, XRX, Restricted Stock Units, RSU vesting, Insider transaction, Form 4, Executive compensation, Stock disposition, Tax withholding

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.